A recent international clinical trial challenges the traditional assumption that coffee should be avoided by patients with atrial fibrillation, a condition that causes irregular heartbeats and affects millions globally. The research, conducted by universities from Califórnia and Austrália, brought to light a new perspective on the consumption of the drink.
The DECAF study, published in November 2025, revealed a significant reduction in the recurrence of arrhythmia episodes in participants who regularly consumed coffee. Essa discovery could redefine medical guidelines for individuals with this heart condition.
The results indicate that daily consumption of caffeinated coffee can reduce the incidence of these beats by 39% in individuals with a history of atrial fibrillation, suggesting an unexpected protective role for the drink.
DECAF Clinical Trial Details
The DECAF study (Does Eliminating Coffee Avoid Fibrillation?) involved 200 participants, from Estados Unidos, Canadá and Austrália, all with a history of atrial fibrillation. Recruitment prioritized patients with persistent atrial fibrillation or associated atrial flutter, ensuring a representative sample for the condition.
All volunteers were habitual coffee consumers before their inclusion in the trial, which made it possible to evaluate the impact of maintaining or abstaining from consumption. Eles had undergone electrical cardioversion to restore normal heart rhythm before monitoring began.
Over a six-month period, participants were randomly divided into two groups: one that consumed at least one cup of caffeinated coffee per day and another that abstained from caffeine completely. Essa randomization occurred shortly after cardioversion, ensuring balance between groups and minimizing bias.
The findings, published in the prestigious journal JAMA, indicate that the group that consumed coffee had 39% fewer recurrences of atrial fibrillation episodes compared to the abstinence group. Heartbeat monitoring was carried out using electrocardiograms and portable devices, ensuring the accuracy of the data collected.
[[_0]
Protective mechanisms of coffee for the heart
Caffeine and other components present in coffee act in multiple ways in the body, as pointed out by the study authors. One of the observed benefits is related to increased physical activity, which is commonly stimulated by drinking the drink. Regular Exercícios are proven to be beneficial in preventing and controlling arrhythmias, contributing to the reduction of atrial fibrillation episodes.
Furthermore, the diuretic action of caffeine can lead to a decrease in blood pressure, relieving stress on the heart muscle. Propriedades Anti-inflammatory ingredients such as polyphenols were also highlighted, as these elements are known to reduce chronic inflammation, a relevant risk factor for several cardiac complications.
The global scenario of atrial fibrillation
Atrial fibrillation is a condition that affects approximately 33 million people worldwide, with an increasing prevalence. Esse increase is primarily driven by the aging global population and the rising rate of obesity, which are known risk factors for the disease.
In the Estados Unidos, diagnoses in adults have doubled in recent decades, affecting around one in three elderly people. No Brasil, Sociedade Brasileira and Cardiologia estimates point to 1.5 million new cases registered annually, highlighting the relevance of the condition for public health.
Positioning of researchers
Gregory Marcus, a UCSF electrophysiologist and senior author of the study, emphasized the unexpected benefits of drinking coffee. “Coffee stimulates daily mobility, a proven protective factor against atrial fibrillation,” he said in a statement, highlighting the need to review old medical guidance on caffeine. Marcus, which occupies Cátedra Endowada in Pesquisa of Fibrilação Atrial, highlighted the importance of new approaches.
Christopher X. Wong, first author of the study and professor at Universidade, Ele, who has a doctorate in cardiovascular epidemiology, pointed out that the recommendation to avoid caffeine can be counterproductive. “Doctors have always suggested moderation, but this trial indicates safety and protection,” said Wong, highlighting the paradigm shift.
Implications for medical practice
The DECAF clinical trial reinforces that moderate coffee consumption — typically one cup a day — does not worsen symptoms in habitual caffeine consumers. Essa information is crucial for reviewing clinical guidelines and counseling patients with atrial fibrillation.
Accurate detection of arrhythmia episodes has been facilitated by continuous monitoring using technologies such as apps and wearables. Esses features allowed researchers to collect detailed, real-time data on participants’ heart health.
The promising results pave the way for larger and more comprehensive studies to investigate the role of caffeine in other forms of cardiac arrhythmias. Future research may further consolidate understanding of the effects of coffee on the cardiovascular system.
Previous scientific knowledge about coffee and arrhythmias
Previous observational studies had already indicated a possible protective relationship between coffee consumption and the risk of arrhythmias. A 2021 survey from UCSF, for example, analyzed data from 386,000 participants, associating each extra cup of coffee with a 3% reduction in the risk of developing arrhythmias.
This research paved the way for DECAF, which stands as the first randomized controlled trial to directly investigate the question. Dados from
Guidelines for conscious consumption
For patients with atrial fibrillation who want to integrate coffee into their routine, some practical recommendations can be followed. Priorizar filtered coffee or espresso, without added sugar, cream or other caloric additives, is essential to maximize the benefits and avoid components that could be harmful to cardiovascular health.
It is advisable to avoid excesses, limiting consumption to one or two cups per day, so as not to interfere with the quality of sleep and other aspects of health. Caffeine can impact the sleep cycle, and adequate rest is vital for heart health. Sempre consult a cardiologist to integrate your coffee habit into your personalized treatment plan, ensuring it is safe and appropriate for your specific condition.
Cardiac monitoring and innovations
Modern devices such as smartwatches and other wearables played a crucial role in the DECAF study by detecting heart irregularities in real time. Esses equipment recorded 64% recurrences of atrial fibrillation in the group that abstained from coffee, in contrast to 47% in the group that consumed the drink, demonstrating the effectiveness of the technology.
Integrating these devices with healthcare apps allows for remote patient tracking, which can reduce the need for frequent hospital visits and optimize medical follow-up. Inovações in artificial intelligence are being developed to analyze cardiac data patterns and predict future arrhythmia episodes, offering an additional layer of prevention and care.
Coffee in Brazilian culture
In Brasil, coffee plays a significant cultural and economic role, with an average consumption of approximately five cups per day, an index that exceeds the global average. The drink is part of morning routines and different times of the day for a large part of the population.
This prevalence makes the findings of the DECAF study directly applicable and of great interest to Brazilians. Local Pesquisas, like those carried out by Fiocruz, continue to explore coffee’s interactions with regional diets and lifestyles, seeking to deepen knowledge about its effects on health in a national context.
